Gene · 3489
Papers1,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IGFBP6 contributes to vascular resilience. | Nat Cardiovasc Res | 2025 | 39794480 | PubTator, text mining | PubMed |
| Endothelial IGFBP6 suppresses vascular inflammation and atherosclerosis. | Nat Cardiovasc Res | 2025 | 39794479 | PubTator, text mining | PubMed |
| Swimming induces physiological cardioprotection associated with pro-growth versus anti-inflammatory influences in extracardiac organs. | Am J Physiol Regul Integr Comp Physiol | 2025 | 39792091 | PubTator, text mining | PubMed |
| miRNA and mRNA Signatures in Human Acute Kidney Injury Tissue. | Am J Pathol | 2025 | 39332675 | PubTator, text mining | PubMed |
| Insulin-like growth factor binding protein-6 modulates proliferative antagonism in response to progesterone in breast cancer. | Front Endocrinol (Lausanne) | 2024 | 39698031 | PubTator, text mining | PubMed |
| Construction and validation of a novel prognostic model with palmitoylation-related genes for glioblastoma. | Transl Cancer Res | 2024 | 39697698 | PubTator, text mining | PubMed |
| Unraveling molecular signatures and prognostic biomarkers in glioblastoma: a comprehensive study on treatment resistance and personalized strategies. | Discov Oncol | 2024 | 39630160 | PubTator, text mining | PubMed |
| scDOT: optimal transport for mapping senescent cells in spatial transcriptomics. | Genome Biol | 2024 | 39516853 | PubTator, text mining | PubMed |
| IGFBP6 Modulates Proteostasis by Activating ATF4 Targets and Reducing ER Retrotranslocon Expression. | Dokl Biochem Biophys | 2024 | 39480639 | PubTator, text mining | PubMed |
| Identification of 10 differentially expressed genes involved in the tumorigenesis of cervical cancer via next-generation sequencing. | PeerJ | 2024 | 39372720 | PubTator, text mining | PubMed |
| Single-cell sequencing analysis and bulk-seq identify IGFBP6 and TNFAIP6 as novel differential diagnosis markers for postburn pathological scarring. | Burns | 2024 | 39317554 | PubTator, text mining | PubMed |
| Deep and unbiased proteomics, pathway enrichment analysis, and protein-protein interaction of biomarker signatures in migraine. | Ther Adv Chronic Dis | 2024 | 39314676 | PubTator, text mining | PubMed |
| Prognostic Value of IGFBP6 in Breast Cancer: Focus on Glucometabolism. | Technol Cancer Res Treat | 2024 | 39275851 | PubTator, text mining | PubMed |
| Excavating regulated cell death signatures to predict prognosis, tumor microenvironment and therapeutic response in HR+/HER2- breast cancer. | Transl Oncol | 2024 | 39241556 | PubTator, text mining | PubMed |
| Combination of transcriptomics and proteomics for analyzing potential biomarker and molecular mechanism underlying skeletal muscle atrophy. | J Proteomics | 2024 | 39179024 | PubTator, text mining | PubMed |
| AP collagen peptides (APCPs) promote hair growth by activating the GSK-3β/β-catenin pathway and improve hair condition. | Exp Dermatol | 2024 | 39031460 | PubTator, text mining | PubMed |
| IGFBP6 regulates extracellular vesicles formation via cholesterol abundance in MDA-MB-231 cells. | Biochimie | 2024 | 38942135 | PubTator, text mining | PubMed |
| A novel role of IGFBP5 in the migration, invasion and spheroids formation induced by IGF-I and insulin in MCF-7 breast cancer cells. | Breast Cancer Res Treat | 2024 | 38896333 | PubTator, text mining | PubMed |
| Muscle Transcriptome Analysis of Mink at Different Growth Stages Using RNA-Seq. | Biology (Basel) | 2024 | 38785766 | PubTator, text mining | PubMed |
| Plasma Proteins Associated with Chronic Histopathologic Lesions on Kidney Biopsy. | J Am Soc Nephrol | 2024 | 38656806 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3489/papers?page=4